Premonitory epidermolysis bullosa acquisita mimicking eyelid dermatitis: Successful treatment with rituximab and protein a immunoapheresis

American Journal of Clinical Dermatology

Volumn 11, Issue 4, 2010, Pages 289-293

  Kubisch, Ilja ^a   Diessenbacher, Philip ^a   Schmidt, Enno ^b   Gollnick, Harald ^a   Leverkus, Martin ^a,c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; COLLAGEN TYPE 7; CORTICOSTEROID; DAPSONE; IMMUNOGLOBULIN G4; PREDNISOLONE; PROTEIN A; RITUXIMAB; TOPICAL ANTIINFECTIVE AGENT;

ADJUVANT THERAPY; AGED; ANTIGEN ANTIBODY REACTION; APHERESIS; ARTICLE; BASEMENT MEMBRANE; BULLOUS PEMPHIGOID; CASE REPORT; DERMATITIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG DOSE INCREASE; EPIDERMOLYSIS BULLOSA ACQUISITA; EROSION; EYELID BIOPSY; EYELID DERMATITIS; EYELID DISEASE; EYELID ERYTHEMA; FEMALE; FOOD INTAKE; HUMAN; IMMUNOAPHERESIS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; MOUTH EXAMINATION; MOUTH LESION; MOUTH MUCOSA; ORAL BLISTER; PATCH TEST; PRIORITY JOURNAL; SPEECH DISORDER; STENOSIS; WESTERN BLOTTING;

AGED; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; DERMATITIS; DIAGNOSIS, DIFFERENTIAL; EPIDERMOLYSIS BULLOSA ACQUISITA; EYELID DISEASES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MICROSCOPY, FLUORESCENCE; PLASMAPHERESIS; REMISSION INDUCTION; STAPHYLOCOCCAL PROTEIN A;

EID: 77953010308     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11533210-000000000-00000     Document Type: Article

References (25)

1. Dang N, Murrell DF. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Exp Dermatol 2008 Jul 7; 17: 553-568
2. Sitaru C. Experimental models of epidermolysis bullosa acquisita. Exp Dermatol 2007 Jun 6; 16: 520-531
3. Woodley DT, Remington J, Chen M. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita. Clin Rev Allergy Immunol 2007 Oct 1-2; 33: 78-84
4. Gammon WR, Briggaman RA, Woodley DT, et al. Epidermolysis bullosa acquisita: a pemphigoid-like disease. J Am Acad Dermatol 1984 Nov; 11 (5 Pt 1): 820-832
5. Hurley D, Boyd JH, Eby C. Laryngeal epidermolysis bullosa acquisita requiring tracheostomy presenting with an acquired factor VIII coagulopathy. Otolaryngol Head Neck Surg 2001 Sep 3; 125: 270-271
6. Elchahal S, Kavosh ER, Chu DS. Ocular manifestations of blistering diseases. Immunol Allergy Clin North Am 2008 Feb 1; 28: 119-36, vii
7. Letko E, Bhol K, Anzaar F, et al. Chronic cicatrizing conjunctivitis in a patient with epidermolysis bullosa acquisita. Arch Ophthalmol 2006 Nov 11; 124: 1615-1618
8. Ritzmann S,Angerstein W, NeumannNJ, et al. Mucosal epidermolysis bullosa acquisita complicated by laryngeal stenosis [in German]. Hautarzt 2004 Oct 10; 55: 974-976
9. Hughes AP, Callen JP. Epidermolysis bullosa acquisita responsive to dapsone therapy. J Cutan Med Surg 2001 Sep 5; 5: 397-399
10. Bibas R, Gaspar NK, Ramos-e-Silva M. Colchicine for dermatologic diseases. J Drugs Dermatol 2005 Mar 2; 4: 196-204
11. Shimanovich I, Nitschke M, Rose C, et al. Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins. Br J Dermatol 2008 Feb 2; 158: 382-388
12. Mihai S, Chiriac MT, Takahashi K, et al. The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita. J Immunol 2007 May 15; 178 (10): 6514-6521
13. Sesarman A, Mihai S, Chiriac MT, et al. Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice. Br J Dermatol 2008 Mar 3; 158: 463-471
14. Kowalzick L, Suckow S, Ziegler H, et al. Mycophenolate mofetil in epidermolysis bullosa acquisita. Dermatology 2003; 207 (3): 332-334
15. Amin KA, Belsito DV. The aetiology of eyelid dermatitis: a 10-year retrospective analysis. Contact Dermatitis 2006 Nov 5; 55: 280-285
16. Ayala F, Fabbrocini G, Bacchilega R, et al. Eyelid dermatitis: an evaluation of 447 patients. Am J Contact Dermat 2003 Jun 2; 14: 69-74
17. Guin JD. Eyelid dermatitis: experience in 203 cases. J Am Acad Dermatol 2002 Nov 5; 47: 755-765
18. Khatri ML, BenghazeilM, Shafi M. Epidermolysis bullosa acquisita responsive to cyclosporin therapy. J Eur Acad Dermatol Venereol 2001 Mar 2; 15: 182-184
19. Maize Jr JC, Cohen JB. Cyclosporine controls epidermolysis bullosa acquisita co-occurring with acquired factor VIII deficiency. Int J Dermatol 2005 Aug 8; 44: 692-694
20. Owsianowski M, Garbe C, Ramaker J, et al. Therapeutic experiences with extracorporeal photopheresis: technical procedure, follow-up and clinical outcome in 31 skin diseases [in German]. Hautarzt 1996 Feb 2; 47: 114-123
21. Gourgiotou K, Exadaktylou D, Aroni K, et al. Epidermolysis bullosa acquisita: treatment with intravenous immunoglobulins. J Eur Acad Dermatol Venereol 2002 Jan 1; 16: 77-80
22. Niedermeier A, Eming R, Pfutze M, et al. Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies). Arch Dermatol 2007 Feb 2; 143: 192-198
23. Sadler E, Schafleitner B, Lanschuetzer C, et al. Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab. Br J Dermatol 2007 Aug 2; 157: 417-419
24. Schmidt E, Benoit S, Brocker EB, et al. Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab. Arch Dermatol 2006 Feb 2; 142: 147-150
25. Wallet-Faber N, Franck N, Batteux F, et al. Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab. Dermatology 2007; 215 (3): 252-255